Get started
Work

Individual and network factors associated with HCV treatment uptake among people who inject drugs

Year: 2020
Type: article
Study design: Observational Study
DOI: 10.1016/j.drugpo.2020.102714
Authors: Oluwaseun Falade-Nwulia, Paul Sacamano, Sean D. McCormick, Cui Yang, Greg Kirk, David Thomas, Mark Sulkowski, Carl Latkin, Shruti H. Mehta
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: green
Funders: Foundation for the National Institutes of Health, National Institutes of Health, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, National Institute on Minority Health and Health Disparities
Awards: Patient-Oriented Research and Mentorship in HIV and Non-Communicable Diseases, G1455601269, G145570320, G1938815669, G2240828507, G2456272280, G2509593258, G2516619799, HIV HCV Coinfection Antiviral Therapy and Fibrosis, Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs, G417997481, G4405713412, G5021622454, G6785452033, G6961451583, G7265264945, G8084044067, G8142833747, G9000072968, G9000074434, G9000121099, G9000121883, G9000320717, AIDS Linked to the IntraVenous Experience (ALIVE) Study, The Johns Hopkins Center for AIDS Research (JHU CFAR)
OpenAlex ID: W3010430917
FWCI: 2.581
Cites: 50
Cited by: 31
Related to: 10